- Report
- April 2024
- 57 Pages
United States
From €1046EUR$1,095USD£890GBP
- Report
- November 2023
- 56 Pages
China
From €1720EUR$1,800USD£1,464GBP
- Report
- November 2023
- 220 Pages
China
From €3823EUR$4,000USD£3,252GBP
- Report
- May 2019
- 23 Pages
United States
From €416EUR$435USD£354GBP
- Report
- May 2023
- 160 Pages
Global
From €5733EUR$5,999USD£4,878GBP
- Report
- May 2023
- 147 Pages
Global
From €5733EUR$5,999USD£4,878GBP
The Generic Drug Production market is a segment of the pharmaceutical industry that focuses on the production of generic drugs. Generic drugs are copies of brand-name drugs that have the same active ingredients, dosage form, strength, route of administration, safety, efficacy, and intended use. Generic drugs are typically much less expensive than their brand-name counterparts, making them a more affordable option for many patients.
Generic drug production involves the manufacture of active pharmaceutical ingredients (APIs) and the formulation of finished dosage forms. APIs are the active ingredients in a drug that are responsible for its therapeutic effects. The production of APIs requires the use of sophisticated manufacturing processes and quality control measures to ensure that the drug is safe and effective. The formulation of finished dosage forms involves the blending of APIs with other inactive ingredients to create a drug product that is ready for use.
Generic drug production is a highly regulated industry, with stringent quality control measures in place to ensure the safety and efficacy of the drugs. Companies in the Generic Drug Production market include Teva Pharmaceuticals, Mylan, Sandoz, and Dr. Reddy's Laboratories. Show Less Read more